LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
All content for i3 Health Podcast is the property of i3 Health and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management
i3 Health Podcast
39 minutes 27 seconds
1 month ago
Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management
Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest strategies for treatment selection and toxicity management—empowering oncology pharmacists to lead confidently, maximize patient outcomes, and deliver next-level care in the evolving era of oral targeted therapies.
🎧 Listen now and click the link to claim your CE credit!
Claim your credit here: https://bit.ly/4pGrLO5
🔗 Learn more and access continuing education activities: https://i3health.com
📲 Stay connected with i3 Health:
Twitter/X: https://bit.ly/42VAYs1
LinkedIn: https://bit.ly/3IMiCmv
Facebook: https://bit.ly/46JrQI2
YouTube: https://bit.ly/4pNhWxR
Instagram: https://bit.ly/4nUSNzE
Threads: https://bit.ly/3Wd6oq9
🎧 Subscribe to the i3 Health Podcast on your favorite streaming platform so you never miss the latest expert discussions!
i3 Health Podcast
LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
